ABLE Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$273K Buy
648
+1
+0.2% +$399 0.04% 191
2026
Q2
$234K Buy
647
+2
+0.3% +$685 0.04% 206
2026
Q1
$227K Buy
645
+1
+0.2% +$356 0.04% 192
2025
Q4
$211K Buy
+644
New +$204K 0.04% 200
2025
Q2
– Sell
-642
Closed -$200K – 206
2025
Q1
$200K Buy
+642
New +$190K 0.06% 195
2024
Q4
– Sell
-645
Closed -$208K – 194
2024
Q3
$208K Hold
645
– – 0.06% 183
2024
Q2
$201K Buy
+645
New +$189K 0.07% 170
2024
Q1
– Sell
-766
Closed -$221K – 159
2023
Q4
$221K Buy
+766
New +$209K 0.1% 140
2023
Q3
– Sell
-967
Closed -$215K – 141
2023
Q2
$215K Buy
967
+41
+4% +$9.5K 0.11% 131
2023
Q1
$224K Buy
+926
New +$227K 0.15% 117

Other funds holding AMGN

ABLE Financial Group's AMGN Position: Q3 2026 in Review

ABLE Financial Group increased its Amgen (AMGN) stake by 0.15% in Q3 2026, buying an estimated $399 and bringing the position to 648 shares worth $273K. The position accounts for 0.04% of the portfolio, ranked #191.

ABLE Financial Group first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. 1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • ABLE Financial Group held 648 shares of Amgen worth $273K as of Q3 2026.
  • ABLE Financial Group bought 1 Amgen share in Q3 2026, an estimated $399.
  • Amgen made up 0.04% of ABLE Financial Group's portfolio in Q3 2026, its #191 holding.
  • ABLE Financial Group first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on ABLE Financial Group's 13F filing for Q3 2026, filed 14 Oct 2026.